Adverse outcomes of anticoagulant use among hospitalized patients with chronic kidney disease: a comparison of the rates of major bleeding events between unfractionated heparin and enoxaparin.

BACKGROUND: Anticoagulation therapy is usually required in patients with chronic kidney disease (CKD) for treatment or prevention of thromboembolic diseases. However, this benefit could easily be offset by the risk of bleeding. OBJECTIVES: To determine the incidence of adverse outcomes of anticoagul...

Full description

Bibliographic Details
Main Authors: Fatemeh Saheb Sharif-Askari, Syed Azhar Syed Sulaiman, Narjes Saheb Sharif-Askari, Ali Al Sayed Hussain, Mohammad Jaffar Railey
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4152258?pdf=render